The Journal of Immunology, Vol 151, Issue 1 100-110, Copyright © 1993 by American Association of Immunologists

ARTICLES

Characterization of a novel CD2+ human thymic B cell subset

J Punnonen and JE de Vries
DNAX Research Institute, Human Immunology Department, Palo Alto, CA 94304-1104.

In the present study, it is demonstrated that functionally mature B cells are present in human thymus early during fetal life. Interestingly, 46 +/- 7% of fetal and postnatal thymic CD19+ B cells co- expressed CD2. Adult peripheral blood or splenic B cells were CD2-, and < 5% of fetal BM or fetal splenic CD19+ cells expressed CD2, indicating that CD2 is expressed preferentially on thymic B cells. Fetal thymic CD2+ B cells have a mature phenotype, because they are CD20+, CD40+, and surface IgM+, but they lack CD34 expression. They are also functionally mature because total thymic cell populations or highly purified CD2+ thymic B cells underwent Ig isotype switching and differentiation into Ig-secreting cells in a similar fashion as conventional B cells after culturing in the presence of IL-4 and activated cloned CD4+ T cells and anti-CD40 mAb cross-linked to Fc gamma RII/CDw32 transfected into murine L cells (Fc gamma RII+/L). Engagement of CD2 on thymic B cells by LFA-3+ L cell transfectants, anti-CD2 mAb cross-linked to Fc gamma RII+/L, or a mitogenic combination of anti-CD2 mAb did not result in proliferation or Ig production under the present conditions. However, anti-CD2 mAb enhanced IL-4 dependent Ig-synthesis by thymic B cells in the presence of activated CD4+ T cells, but they were ineffective when the B cells were activated by anti-CD40 mAb, suggesting that the anti-CD2 mAb stimulated antibody production indirectly via CD4+ T cells. Similarly, IL-7 enhanced IL-4-induced Ig production in the presence of CD4+ T cells. This effect of IL-7 also appeared to be indirect because no enhancement in Ig levels was observed in cultures of purified thymic B cells. Collectively, our results indicate that functionally mature B cells are present in human thymus early during fetal life, and that thymic CD2+, CD19+, sIgM+ cells represent a subset of bona fide B cells, which can be induced to Ig isotype switching and Ig production in vitro in a similar fashion as conventional B cells.

This article has been cited by other articles:

				J. K. Lee, S. O. Mathew, S. V. Vaidya, P. R. Kumaresan, and P. A. Mathew CS1 (CRACC, CD319) Induces Proliferation and Autocrine Cytokine Expression on Human B Lymphocytes J. Immunol., October 1, 2007; 179(7): 4672 - 4678. [Abstract] [Full Text] [PDF]

				O. Perez, M. Lastre, J. Lapinet, G. Bracho, M. Diaz, C. Zayas, C. Taboada, and G. Sierra Immune Response Induction and New Effector Mechanisms Possibly Involved in Protection Conferred by the Cuban Anti-Meningococcal BC Vaccine Infect. Immun., July 1, 2001; 69(7): 4502 - 4508. [Abstract] [Full Text] [PDF]

				V. de Mello-Coelho, M.-C. Gagnerault, J.-C. Souberbielle, C. J. Strasburger, W. Savino, M. Dardenne, and M.-C. Postel-Vinay Growth Hormone and Its Receptor Are Expressed in Human Thymic Cells Endocrinology, September 1, 1998; 139(9): 3837 - 3842. [Abstract] [Full Text] [PDF]

				J. Punnonen, B. G. Cocks, J. M. Carballido, B. Bennett, D. Peterson, G. Aversa, and J. E. d. Vries Soluble and Membrane-bound Forms of Signaling Lymphocytic Activation Molecule (SLAM) Induce Proliferation and Ig Synthesis by Activated Human B Lymphocytes J. Exp. Med., March 17, 1997; 185(6): 993 - 1004. [Abstract] [Full Text] [PDF]